Recombinant factor VIIa (rFVIIa) and its use in severe bleeding in surgery and trauma: a review
- 1 September 2003
- journal article
- review article
- Published by Elsevier in Blood Reviews
- Vol. 17, S11-S21
- https://doi.org/10.1016/s0268-960x(03)90002-6
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapyLiver Transplantation, 2003
- Recombinant factor VIIa in orthotopic liver transplantationBlood Coagulation & Fibrinolysis, 2003
- Systematic review of the use of fibrin sealant to minimize perioperative allogeneic blood transfusionBritish Journal of Surgery, 2002
- An Effective Treatment of Severe Intractable Bleeding After Valve Repair by One Single Dose of Activated Recombinant Factor VIIAnesthesia & Analgesia, 2001
- REDUCED TRANSFUSION REQUIREMENTS BY RECOMBINANT FACTOR VIIa IN ORTHOTOPIC LIVER TRANSPLANTATIONTransplantation, 2001
- Fibrin SealantDrugs, 1999
- PHYSIOLOGICAL PREDICTORS OF DEATH IN EXSANGUINATING TRAUMA PATIENTS UNDERGOING CONVENTIONAL TRAUMA SURGERYAnz Journal of Surgery, 1998
- Metabolic AcidosisAACN Advanced Critical Care, 1997
- Evaluating Trauma CarePublished by Wolters Kluwer Health ,1987
- TraumaScientific American, 1983